The EPFL Innovation Park supports disruptive innovations and the transfer of technologies of the EPFL and other regional academic partners. It provides flexible office space, training, acceleration and coaching services to 250 high-tech companies: start-ups, SMEs and R&D centres of large companies. Together with its partners and a dynamic community of venture capital firms, experts and service providers, the Innovation Park is positioned as the main pole of entrepreneurship in Western Switzerland.
Over 1.3 million individual customers as well as some 24,000 companies are insured with Groupe Mutuel. Its overall turnover exceeds CHF 5.6 billion.
In addition to compulsory health insurance (LAMal/KVG) and supplemental insurance (LCA/VVG), customers can choose from an extensive range of life insurance plans to cover risks and provide for their individual retirement benefits, as well as from a range of patrimony insurance solutions (legal protection, private liability insurance and household contents insurance). Moreover, Groupe Mutuel insurers provide daily allowance insurance to companies, pursuant to LAMal/KVG and LCA/VVG, as well as compulsory accident insurance (LAA/UVG). Groupe Mutuel also manages Groupe Mutuel Prévoyance-GMP pension fund.
BioAlps, the Life Sciences cluster of Western Switzerland, offers a dynamic network, an innovative and supportive environment, and immediate access to the world of Life Sciences. It comprises an active and fertile ecosystem of research institutions, academic institutions, start-up companies and large multinationals concentrated in a small, attractive geographic area with a great infrastructure.
CSEM is a Swiss private, non-profit research and technology organization with +35 year of Deep Tech development and transfer to industry. CSEM has become increasingly active in the domain of biotech and the life sciences. We use our miniaturization, integration, and microengineering expertise to develop new devices, with a focus on components, tools, and systems for toxicology and pharmacology, and on diagnostics and assays.
We play a key role in the innovation value chain, leveraging public-private partnerships and narrowing the gap between fundamental research and industrialization. And by taking steps to deepen CSEM’s knowledge and adapt it to industrial needs, we are able to bring new products to market and create new ventures.
At DayOne, we are shaping the future of health by accelerating digital transformation in Europe’s leading healthcare and life sciences hub. As the Healthcare Innovation initiative by Basel Area Business & Innovation, DayOne believes in a patient-centric and sustainable approach to healthcare.
We have built a platform for collaborative innovation across disciplines and industries by accelerating startups, launching catalyst projects and hosting a community and events to bring healthcare innovation ventures forward. Join us in creating a world-leading hub for healthcare innovation, built on the strength of the Basel Area.
The Embassy’s Swissnex team is part of the Swiss global network connecting Switzerland and the world in education, research and innovation. Our mission is to support the outreach and active engagement of partners in the international exchange of knowledge, ideas and talent. We thereby contribute to strengthen Switzerland's profile as a world-leading science and innovation hotspot.
Essity Ventures is a strategic initiative of Essity, a global, leading, health and hygiene company with a mission to break barriers to wellbeing. As a global leader, we leverage our expertise and resources to help start-ups build credibility and accelerate their growth towards commercial success. We seek for Innovative start-ups and entrepreneurs who share our mission to partner with us in connecting the dots between innovation and expertise to revolutionize the future of health and hygiene.
Our particular focus will be on Feminine Care and Women’s health, tapping into areas such as Femtech, Period pain and Menopause. We also have a high interest in start-ups tapping into the Sustainability, Incontinence, Consumer tissue, Professional Hygiene, Personal Care and Baby care area.
FemTech Analytics (FTA) is a strategic analytics agency focused on relatively young yet already treated as the next big market disruptor FemTech market, which embraces the cornerstone subsectors such as Longevity for women, Mental Health & Healthy Lifestyle, Reproductive Health, and General Healthcare. The range of activities includes research and in-depth analysis on major areas of high potential in the FemTech industry, maintaining profiling of companies and governmental agencies based on their innovation potential and business activity, and providing consulting and analytical services to advance the FemTech sector.
Fermata accelerates the development of the FemTech ecosystem and a community that celebrates diversity in society, creates a place for women to share their concerns and issues related to their bodies, curates FemTech products from around the world and provides solutions in Asia.
The INSEAD Healthcare Club brings together students who wish to pursue a career in the healthcare industry, those who are seeking to return to the healthcare industry, and students who simply want to learn more about this fast-growing sector.
Joyance Partners is the first venture fund focused on finding and growing new companies that deliver Delightful Moments derived from science. Delightful Moments are part of all human experience: the small, but powerful, separations from the daily humdrum when we feel stronger, calmer, more joyful, more in control, more distant from pain and anxiety.
Now, emerging science and technology present the potential to deliver these experiences. Science can help individuals be a bit happier, which can lead to greater health. Or a little healthier, which can lead to greater potential for happiness. It is a new, transformative cycle of human experience.
This new science of health and happiness ranges from transforming the human organism (genetics, bioscience), to creating new forms of human chemistry (the microbiome), to reading, understanding or altering our minds (neuroscience), to expanding human experience (virtual and augmented reality), and even to altering what we eat and drink (next-generation food) and how we interact with one another (emergent community).
It is a new, transformative cycle of human experience that we see as one of the greatest investment opportunities in decades, a $15 Trillion market opportunity.
RH Capital is a wholly-owned, for-profit subsidiary of Rhia Ventures. RH Capital’s venture funds invest in early and growth-stage companies that are driving innovation, access, and equity across the reproductive and maternal health landscape while delivering strong financial returns to investors. As impact investors, our unique mission of seeking both financial and social returns attracts inspiring and talented entrepreneurs who share a common vision—to improve the health of all women in the US. Underlying all of our work is a continued commitment to gender and racial equity.
Over our 125-year history, Roche has grown into one of the world’s largest biotech companies, a leading provider of in-vitro diagnostics, and a global supplier of transformative innovative solutions across major disease areas. As part of our commitment to providing the best possible care for every individual, we are on a mission to work with partners across the ecosystem to highlight and tackle some of the persistent challenges women face in healthcare.
SICTIC is a non-profit organization and the largest Business Angel Network in Switzerland, connecting the most innovative Swiss seed and early-stage tech startups to smart money investors. SICTIC's mission is to shape the investor and startup ecosystem in Switzerland by growing the quantity and quality of Swiss early-stage startup investments. SICTIC is committed to helping Swiss tech startups succeed, creating new jobs, and contributing to Switzerland's economic development.
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
Swissnex is an initiative of the State Secretariat for Education, Research and Innovation and is part of the Confederation’s network abroad managed by the FederalDepartment of Foreign Affairs. The activities of Swissnex are based on a collaborative approach, relying on public and private partnerships and funding.
Swissnex collaborates with a broad spectrum of partners related to international research and innovation. Their mission is to support the outreach and active engagement of their partners in the international exchange of knowledge, ideas and talent.
Women of Wearables (WoW) is a leading global organisation aiming to inspire, connect, and support women and allies in emerging technologies such as wearable tech, IoT, health tech, and everything in between.
With headquarters in London (UK) and more than 20,000 members located around the globe, WoW has become a global movement that supports its growing community through events, mentorship, educational programs, and collaboration with its network of local collaborators and partners. Our members are startup founders, designers, technologists, industry experts, researchers, bloggers, journalists, investors, and many more.